Amelenodor

MedChem Express

Amelenodor

5

Research Use Only

98.47

C24H21N3O3

399.44

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohns disease and ulcerative colitis [1] [2] .

CC1=NC(OC2=CC(OC3=CC=CC(C)=N3)=CC(OC4=CC=CC(C)=N4)=C2)=CC=C1

-20°C,2°C to 8°C

12352200